New Society of Healthcare Epidemiology Of America (SHEA) Guidelines Include Agion Antimicrobial-Treated Catheters

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

WAKEFIELD, Mass.--(BUSINESS WIRE)--Use of catheters containing the Agion® antimicrobial is among the recommended strategies to control central line-associated bloodstream infections (CLABSI) according to the Society for Healthcare Epidemiology of America (SHEA).

An expert guidance document published in Infection Control and Hospital Epidemiology in July 2014 and sponsored by SHEA1 provides best evidence practices for the prevention of central-line associated bloodstream infections. As part of the 2014 updates, the authors recommend the use of “silver zeolite–impregnated umbilical catheters in preterm infants,” based on the 2012 study by Bertini2 on the “Reduction of catheter-related bloodstream infections in preterm infants by the use of catheters with the Agion Antimicrobial System.”

Hey, check out all the research scientist jobs. Post your resume today!

Back to news